MedPath

TERAZOSIN

TERAZOSIN

Approved
Approval ID

3109caa1-3388-41b4-ab9a-aee009c7326d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 19, 2015

Manufacturers
FDA

Northwind Pharmaceuticals, LLC

DUNS: 036986393

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

terazosin hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51655-676
Application NumberANDA075317
Product Classification
M
Marketing Category
C73584
G
Generic Name
terazosin hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateMarch 19, 2015
FDA Product Classification

INGREDIENTS (1)

TERAZOSIN HYDROCHLORIDEActive
Quantity: 5 mg in 1 1
Code: D32S14F082
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.